CD4 and cervicitis: Since there is no level of absolute CD4 count that puts HIV-1-positive women at lower risk for persistent infection with oncogenic HPV and cervical disease development, we suggest that HIV-1-positive women may be ideal for individualized HPV vaccination of adult HIV-positive women, a similar suggestion as proposed by Dlamini et al.[49]